These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 34807506)
1. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance. Qiao X; Zhu L; Song R; Shang C; Guo Y Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer. Qiao X; Liu J; Zhu L; Song R; Zhong M; Guo Y Int J Med Sci; 2021; 18(16):3728-3737. PubMed ID: 34790046 [TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway. Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019 [TBL] [Abstract][Full Text] [Related]
5. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling. Lu M; Wang C; Chen W; Mao C; Wang J DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705 [TBL] [Abstract][Full Text] [Related]
6. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982 [TBL] [Abstract][Full Text] [Related]
7. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma. de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of methyltransferase-like 3 and 14 in oral squamous cell carcinoma. Wu S; Makeudom A; Sun X; Li X; Xu D; Sastraruji T; Lumbikananda N; Buranaphatthana W; Krisanaprakornkit S J Oral Pathol Med; 2022 Feb; 51(2):134-145. PubMed ID: 34689367 [TBL] [Abstract][Full Text] [Related]
10. GAS5 alleviates cisplatin drug resistance in oral squamous cell carcinoma by sponging miR-196a. Yuan X; Jing Y; Guang M; Zhu J; Wang J; Wang Y; Zhang Y J Int Med Res; 2022 Oct; 50(10):3000605221132456. PubMed ID: 36310502 [TBL] [Abstract][Full Text] [Related]
11. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway. Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026 [TBL] [Abstract][Full Text] [Related]
12. Regulation of transforming growth factor-beta1 by circANKS1B/miR-515-5p affects the metastatic potential and cisplatin resistance in oral squamous cell carcinoma. Yan J; Xu H Bioengineered; 2021 Dec; 12(2):12420-12430. PubMed ID: 34781814 [TBL] [Abstract][Full Text] [Related]
13. Hedgehog signaling promotes multidrug resistance by regulation of ABC transporters in oral squamous cell carcinoma. Lu X; Wang Z; Huang H; Wang H J Oral Pathol Med; 2020 Oct; 49(9):897-906. PubMed ID: 32512620 [TBL] [Abstract][Full Text] [Related]
14. METTL3 Intensifies the Progress of Oral Squamous Cell Carcinoma via Modulating the m6A Amount of PRMT5 and PD-L1. Ai Y; Liu S; Luo H; Wu S; Wei H; Tang Z; Li X; Lv X; Zou C J Immunol Res; 2021; 2021():6149558. PubMed ID: 34476262 [TBL] [Abstract][Full Text] [Related]
15. Oxymatrine suppresses oral squamous cell carcinoma progression by suppressing CXC chemokine receptor 4 in an m Luo R; Xie L; Lin Y; Shao J; Lin Z Oncol Rep; 2022 Oct; 48(4):. PubMed ID: 36004481 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma. Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558 [TBL] [Abstract][Full Text] [Related]
18. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798 [TBL] [Abstract][Full Text] [Related]
19. SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification. Huang J; Li H; Yang Z; Liu R; Li Y; Hu Y; Zhao S; Gao X; Yang X; Wei J Cell Death Dis; 2024 Feb; 15(2):139. PubMed ID: 38355684 [TBL] [Abstract][Full Text] [Related]
20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance. Su L; Wang Y; Xiao M; Lin Y; Yu L Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]